[HTML][HTML] In-hospital mortality of high-risk pulmonary embolism: a nationwide population-based cohort study in Portugal from 2010 to 2018

R Calé, R Ascenção, C Bulhosa, H Pereira, M Borges… - Pulmonology, 2024 - Elsevier
Background The mortality associated with high-risk pulmonary embolism (PE) is remarkably
high, and reperfusion to unload right ventricle should be a priority. However, several …

Comparison of thrombolysis and anticoagulation in pulmonary thromboembolism: a meta-analysis

ZQ Qin, C Wang - Zhonghua jie he he hu xi za zhi= Zhonghua Jiehe …, 2003 - europepmc.org
OBJECTIVE: To pool the data of studies about thrombolysis in pulmonary thromboembolism
(PTE) and evaluate the efficacy and safety of thrombolysis. METHODS: The randomized …

[PDF][PDF] Contemporary outcomes in patients hospitalized with pulmonary embolism: what can we learn from observational data?

A Sharp, F Mahfoud - European Heart Journal, 2024 - oxfordjournals.org
Contemporary outcomes in patients hospitalized with pulmonary embolism: what can we learn
from observational data? Page 1 Contemporary outcomes in patients hospitalized with …

Management of low-risk pulmonary embolism patients without hospitalization: the low-risk pulmonary embolism prospective management study

JR Bledsoe, SC Woller, SM Stevens, V Aston, R Patten… - Chest, 2018 - Elsevier
Background The efficacy and safety of managing patients with low-risk pulmonary embolism
(PE) without hospitalization requires objective data from US medical centers. We sought to …

Unsolved issues in the treatment of pulmonary embolism

SZ Goldhaber - Thrombosis research, 2001 - Elsevier
The three most controversial and unsolved issues in the treatment of pulmonary embolism
(PE) are:(1) the role of thrombolysis,(2) the role of low molecular weight heparin and length …

Impact of Reperfusion on Clinical Outcomes in Patients with Intermediate-High Risk Pulmonary Embolism

L Bobadilla, CE Scatularo, M Antoniolli… - Current Problems in …, 2022 - Elsevier
The prognosis of pulmonary embolism (PE) depends on its correct stratification, and
reperfusion in intermediate-risk pulmonary embolism is controversial yet. Our aim is to …

Predictors of mortality from pulmonary embolism and their influence on clinical management

C Becattini, G Agnelli - Thrombosis and haemostasis, 2008 - thieme-connect.com
T he incidence of pulmonary embolism (PE) is about 1 per 1,000 in the general population
and increases with age (1–2). The annual age-adjusted mortality due to PE is around 2.7 …

[引用][C] Reperfusion therapies in patients with intermediate-and high-risk pulmonary embolism: insights from a multicenter registry

C Real, C Ferrera… - European Heart …, 2024 - Oxford University Press US

Does In-Hospital Mortality Vary Between Pulmonary Embolism Therapies? A Systematic Review and Model-based Meta-analysis

S Fu, N Anderson, AO Williams, MR Jaff… - Journal of Vascular …, 2023 - jvsvenous.org
Objective Pulmonary embolism (PE) is a common and potentially life-threatening condition
that often requires prompt and aggressive treatment. Anticoagulation, systemic thrombolysis …

Effectiveness and safety of half-dose thrombolysis in intermediate-high risk pulmonary embolism: a single centre experience

C Picariello, G Zagarese, V Santori… - … Heart Journal: Acute …, 2024 - academic.oup.com
Abstract Funding Acknowledgements None. Introduction According to current guidelines, full-
dose systemic thrombolysis for pulmonary embolism (PE) is limited to patients either …